Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04467801
Title Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy (Ipat-Lung)
Acronym Ipat-Lung
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Jun Zhang, MD, PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Cancer Center (KUCC) RECRUITING Fairway Kansas 66205 United States Details
The University of Kansas Cancer Center, Westwood Campus RECRUITING Kansas City Kansas 66205 United States Details
The University of Kansas Cancer Center, Overland Park Clinic ACTIVE_NOT_RECRUITING Overland Park Kansas 66210 United States Details
The University of Kansas Cancer Center, North Clinic ACTIVE_NOT_RECRUITING Kansas City Missouri 64154 United States Details
The University of Kansas Cancer Center, Lee's Summit Clinic ACTIVE_NOT_RECRUITING Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field